References
- Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64:9-29; PMID:24399786; http://dx.doi.org/10.3322/caac.21208
- Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet 2011; 378:607-20; PMID:21620466; http://dx.doi.org/10.1016/S0140-6736(10)62307-0
- Konstantinidis IT, Warshaw AL, Allen JN, Blaszkowsky LS, Castillo CF, Deshpande V, Hong TS, Kwak EL, Lauwers GY, Ryan DP, et al. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advancedunresectable tumors? What is a "true" R0 resection? Ann Surg 2013; 257:731-6; PMID:22968073; http://dx.doi.org/10.1097/SLA.0b013e318263da2f
- Jang JY, Kang MJ, Heo JS, Choi SH, Choi DW, Park SJ, Han SS, Yoon DS, Yu HC, Kang KJ, et al. A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer. Ann Surg 2014; 259:656-64; PMID:24368638; http://dx.doi.org/10.1097/SLA.0000000000000384
- Farnell MB, Pearson RK, Sarr MG, DiMagno EP, Burgart LJ, Dahl TR, Foster N, Sargent DJ. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 2005; 138:618-28; PMID:16269290; http://dx.doi.org/10.1016/j.surg.2005.06.044
- Luo GP, Xiao ZW, Long J, Liu ZQ, Liu L, Liu C, Xu J, Ni QX, Yu XJ. CA125 is superior to CA19-9 in predicting the resectability of pancreatic cancer. J Gastrointest Surg 2013; 17:2092-8; PMID:24146342; http://dx.doi.org/10.1007/s11605-013-2389-9
- Xu HX, Chen T, Wang WQ, Wu CT, Liu C, Long J, Xu J, Zhang YJ, Chen RH, Liu L, et al. Metabolic tumour burden assessed by ⁸F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection. Eur J Nucl Med Mol Imaging 2014; 41:1093-102; PMID:24522797; http://dx.doi.org/10.1007/s00259-014-2688-8
- Liu L, Xu HX, Wang WQ, Wu CT, Chen Y, Yang J, Cen P, Xu J, Liu C, Long J, et al. A preoperative serum signature of CEA+ /CA125+ /CA19-9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer. Int J Cancer 2015 May 1;136(9):2216–27; PMID:25273947; http://dx.doi.org/10.1002/ijc.29242
- Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013; 369(18):1691-703; PMID:24131140; http://dx.doi.org/10.1056/NEJMoa1304369
- Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardière C, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011; 364(19):1817-25; PMID:21561347; http://dx.doi.org/10.1056/NEJMoa1011923
- Zhang B, Xu J, Liu C, Long J, Liu L, Xu YF, Wu CT, Luo GP, Ni QX, Li M, et al. Application of “papillary-like main pancreatic duct invaginated” pancreaticojejunostomy for normal soft pancreas cases. Sci Rep 2013; 3:2068; PMID:23797701; http://dx.doi.org/10.1038/srep02068
- Liu C, Long J, Liu L, Xu J, Zhang B, Yu XJ, Ni QX. Pancreatic stump-closed pancreaticojejunostomy can be performed safely in normal soft pancreas cases. J Surg Res 2012; 172:e11-7; PMID:22079848; http://dx.doi.org/10.1016/j.jss.2011.09.002
- Wu CT, Xu WY, Liu L, Long J, Xu J, Ni QX, Liu C, Yu XJ. Ligamentum teres hepatis patch enhances the healing of pancreatic fistula after distal pancreatectomy. Hepatobiliary Pancreat Dis Int 2013; 12:651-5; PMID:24322752; http://dx.doi.org/10.1016/S1499-3872(13)60102-2